125 related articles for article (PubMed ID: 2412030)
1. Platelet serotonin in essential hypertension and in mental depression.
Baudouin-Legros M; Le Quan-Bui KH; Guicheney P; Kamal LA; Meyer P
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S12-4. PubMed ID: 2412030
[TBL] [Abstract][Full Text] [Related]
2. Maprotiline in the treatment of endogenous depression: comparison of therapeutic effect with serotonin level in blood platelets.
Mück-Seler D; Deanović Z; Jamnicky B; Jakupcević M; Mihovilović M
Psychopharmacology (Berl); 1983; 79(2-3):262-5. PubMed ID: 6189139
[TBL] [Abstract][Full Text] [Related]
3. [Reduction of platelet serotonin in major depression (endogenous depression)].
Kim HL; Plaisant O; Leboyer M; Gay C; Kamal L; Devynck MA; Meyer P
C R Seances Acad Sci III; 1982 Nov; 295(10):619-22. PubMed ID: 6819060
[TBL] [Abstract][Full Text] [Related]
4. Platelet 3H-paroxetine binding in depressed patients.
D'haenen H; De Waele M; Leysen JE
Psychiatry Res; 1988 Oct; 26(1):11-7. PubMed ID: 2976947
[TBL] [Abstract][Full Text] [Related]
5. [Sensitivity of the retrograde uptake of H3-serotonin to imipramine and trazodone in patients with endogenous depression treated with antidepressive drugs].
Katasonov AB; Beliaev BS; Zlobina GP; Faktor MI; Brusov OS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):125-8. PubMed ID: 2728713
[TBL] [Abstract][Full Text] [Related]
6. Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
Schlake HP; Kuhs H; Rolf LH; Bosse T; Schuhknecht E; Rudolf GA; Brune GG
Acta Psychiatr Scand Suppl; 1989; 350():149-51. PubMed ID: 2530775
[No Abstract] [Full Text] [Related]
7. Does platelet serotonin receptor supersensitivity accompany endogenous depression?
Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Factor MI; Lideman RR
Biol Psychiatry; 1989 Feb; 25(4):375-81. PubMed ID: 2930807
[TBL] [Abstract][Full Text] [Related]
8. Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.
Mück-Seler D; Jakovljević M; Deanović Z
J Affect Disord; 1991 Nov; 23(3):157-64. PubMed ID: 1774431
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of rat tail bleeding time by ketanserin: mechanisms of action.
Buczko W; Gambino MC; De Gaetano G
Eur J Pharmacol; 1984 Aug; 103(3-4):261-8. PubMed ID: 6237923
[TBL] [Abstract][Full Text] [Related]
10. Uptake of 5-hydroxytryptamine and dopamine into platelets from depressed patients and normal subjects--influence of clomipramine, desmethylclomipramine and maprotiline.
Ehsanullah RS
Postgrad Med J; 1980; 56 Suppl 1():31-5. PubMed ID: 7393826
[TBL] [Abstract][Full Text] [Related]
11. Reduced serotonin content and uptake in platelets from patients with essential hypertension: is a ouabain-like factor involved?
Guicheney P; Baudouin-Legros M; Valtier D; Meyer P
Thromb Res; 1987 Feb; 45(4):289-97. PubMed ID: 3576517
[TBL] [Abstract][Full Text] [Related]
12. [Activity of platelet serotonin receptors of patients with endogenous depression before and after treatment with antidepressive agents].
Katasonov AB; Beliaev BS; Brusov OS; Zlobina GP; Faktor MI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(12):75-8. PubMed ID: 2633575
[TBL] [Abstract][Full Text] [Related]
13. Effects of ketanserin on platelet function and red cell filterability in hypertension and peripheral vascular disease.
Zannad F; Voisin P; Pointel JP; Schmitt C; Freitag B; Stoltz JF
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S32-4. PubMed ID: 2412053
[TBL] [Abstract][Full Text] [Related]
14. [Function of the serotoninergic system of blood platelets in patients with hypertension].
Krivonkin KIu; Belousov IuB; Brusov OS; Katasonov AB; Zlobina GP; Faktor MI
Kardiologiia; 1992; 32(11-12):10-2. PubMed ID: 1297866
[TBL] [Abstract][Full Text] [Related]
15. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing platelet serotonin uptake in essential hypertension.
Jafri SM; Chandra N; Dhawan S; Soni D; Chandra M; Shanker K
Int J Cardiol; 1992 Mar; 34(3):327-33. PubMed ID: 1563858
[TBL] [Abstract][Full Text] [Related]
17. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
Andersson A; Marcusson J
Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
[TBL] [Abstract][Full Text] [Related]
18. Effect of ketanserin on the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases.
De Cree J; Leempoels J; Demoen B; Roels V; Verhaegen H
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S26-8. PubMed ID: 2412051
[TBL] [Abstract][Full Text] [Related]
19. Further studies on platelet serotonin transporter binding in depression.
Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
[TBL] [Abstract][Full Text] [Related]
20. [Development of subsensitivity to imipramine in the system of reverse serotonin uptake by thrombocytes in patients with endogenous depression].
Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Faktor MI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(9):96-100. PubMed ID: 3232463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
